Accessibility Menu
 
Pharmagreen Biotech logo

Pharmagreen Biotech

(OTC) PHBI

Current Price$0.00
Market Cap$1.19M
Since IPO (2018)-100%
5 Year-94%
1 Year+29%
1 Month-5%

Pharmagreen Biotech Financials at a Glance

Market Cap

$1.19M

Revenue (TTM)

$3.42M

Net Income (TTM)

$557.02K

EPS (TTM)

$-0.00

P/E Ratio

-4.50

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Price

$0.00

Volume

50,488

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

PHBI News

No articles available.

PHBI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharmagreen Biotech

Industry

Pharmaceuticals

CEO

Peter Wojcik

Headquarters

Coquitlam, BC V3E 3A2, CA

PHBI Financials

Key Financial Metrics (TTM)

Gross Margin

-0%

Operating Margin

-37%

Net Income Margin

-16%

Return on Equity

0%

Return on Capital

14%

Return on Assets

-94%

Earnings Yield

-22.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.19M

Shares Outstanding

663.65M

Volume

50.49K

Short Interest

0.00%

Avg. Volume

2.22M

Financials (TTM)

Gross Profit

$1.74K

Operating Income

$248.00K

EBITDA

$971.18K

Operating Cash Flow

$28.09K

Capital Expenditure

$4.00

Free Cash Flow

$28.09K

Cash & ST Invst.

$276.00

Total Debt

$356.24K

Pharmagreen Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.42M

+682948.3%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.19M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$1.10M

-41.4%

EBITDA

$1.12M

-45.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$261.80K

+26.5%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$266.07K

+0.2%

Return on Assets

-94.08%

N/A

Return on Invested Capital

13.71%

N/A

Free Cash Flow

$3.82K

-487.7%

Operating Cash Flow

$3.82K

-484.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CBDYTarget Group Inc.
$0.00+18.75%
MJNAMedical Marijuana, Inc.
$0.00+0.00%
MSTHMystic Holdings, Inc.
$0.01+0.00%
CNNACann American Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.53-0.33%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About PHBI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.